Clinical trials: Healthy Adult Female Participants
Healthy Participants
Phase 1 Single and Multiple Ascending Dose of LTG-321 in Healthy Participants
This is a first-in-human, randomized, double-blind, placebo-controlled Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics…
- Trial name
- NCT07110610
- Testing
- LTG-321
- Where
- New Zealand
- Volunteers
- 112 people, healthy volunteers welcome
- Sponsor
- Latigo Biotherapeutics
Healthy Participants
A Study to Understand the Effects of Carbamazepine on How Vepdegestrant is Processed in Healthy Participants
The purpose of this study is to understand if carbamazepine reacts with vepdegestrant and affects how it is processed in the bodies of healthy participants.
- Trial name
- PK (NCT06005688)
- Testing
- Vepdegestrant, Carbamazepine
- Where
- Belgium
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- Pfizer